title: Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella.
abstract: An age shift in rubella infection to young adults has occurred in Scotland since the introduction of a first dose measles, mumps and rubella (MMR) vaccination in 1988 and a second dose measles/rubella (MR) vaccination in 1994/95. The Health Board was alerted to an outbreak of rubella at Stirling University by the notification of 6 cases amongst male students aged 18-28 years with dates of onset between 3 March and 21 March 1996. In response, a MR vaccination campaign was conducted to enhance population immunity to rubella within the university population and to reduce the likelihood of further cases. A total of 1795 students, staff and visitors were vaccinated. Vaccine coverage of 46% was estimated to be sufficient to boost rubella immunity in full time male students in university accommodation to 88.7-91.0%, just above the upper critical level of herd immunity for rubella of 85-88%. Students in colleges and universities in the UK will remain at increased risk of outbreaks of rubella and measles until the cohort who have received a two dose schedule of MR form the bulk of the college population. It may be prudent for tertiary education colleges and other institutions in the UK with young adults living in shared residential accommodation to offer MR vaccination to new entrants, targeting those who have not previously received the vaccine, between now and the year 2000.
authors.affiliation: Argyll and Clyde Health Board, Paisley, UK.
authors.forename: J
authors.initials: J
authors.lastname: Stevenson
authors.forename: G
authors.initials: G
authors.lastname: Murdoch
authors.forename: A
authors.initials: A
authors.lastname: Riley
authors.forename: B
authors.initials: B
authors.lastname: Duncan
authors.forename: M
authors.initials: M
authors.lastname: McWhirter
authors.forename: P
authors.initials: P
authors.lastname: Christie
mesh_terms: D000293:Adolescent; D000328:Adult; D004196:Disease Outbreaks / Q000517:prevention & control; D005260:Female; D006801:Humans; D017589:Immunization Programs; D008297:Male; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage*; D012409:Rubella / Q000453:epidemiology / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage*; D013334:Students; D006113:United Kingdom / Q000453:epidemiology; D014495:Universities
chemical_list: D008458:Measles Vaccine; D012411:Rubella Vaccine